Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

QUEST DIAGNOSTICS INC Director's Dealing 2026

Feb 20, 2026

30275_dirs_2026-02-20_ffcdcf6c-2975-4cbb-9df7-f4ae2a7a33be.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: QUEST DIAGNOSTICS INC (DGX)
CIK: 0001022079
Period of Report: 2026-02-18

Reporting Person: Plewman Patrick (SVP for Diagnostic Services)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2026-02-18 Common Stock A 1952 Acquired 17333 Direct
2026-02-18 Common Stock F 244 $210.01 Disposed 17089 Direct
2026-02-18 Common Stock F 293 $206.99 Disposed 16796 Direct
2026-02-19 Common Stock S 958 $204.83 Disposed 15838 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2026-02-18 Non-Qualifed Stock Option (right to buy) $204.96 A 9009 Acquired 2036-02-18 Common Stock (9009) Direct

Footnotes

F1: Represents an award of restricted stock units.

F2: Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the vesting of restricted stock units.

F3: This exercise and sale reported were effected pursuant to a Rule 10b5-1 sales plan adopted by the reporting person.

F4: The options vest in three equal annual installments beginning on the first annual anniversary of the grant date.